CHARLESTOWN, Mass., Dec. 01, 2022 (GLOBE NEWSWIRE) — Solid Biosciences Inc. (Nasdaq: SLDB), a life sciences company focused on advancing meaningful therapies… Continue Reading
Articles
Surgical Innovation Associates (SIA) Announces Definitive Agreement to be Acquired by Integra LifeSciences
Transaction, valued up to $140M, will accelerate market entry for plastic and reconstructive surgical devices CHICAGO–(BUSINESS WIRE)– Surgical Innovation Associates (SIA) today… Continue Reading
Millstone Medical Outsourcing Completes Acquisition of Ethide Labs
Expands capabilities in EO residual and microbiology testing for medical devices FALL RIVER, Mass., Dec. 1, 2022 /PRNewswire/ — Millstone Medical Outsourcing,… Continue Reading
M&A: NextGen Healthcare to Acquire TSI Healthcare for $68M
What You Should Know: NextGen Healthcare today announced it has signed a definitive agreement to acquire TSI Healthcare, a privately held value-added… Continue Reading
Lilly Completes Acquisition of Akouos Expanding Efforts to Help People with Genetic Diseases
INDIANAPOLIS, Dec. 1, 2022 /PRNewswire/ — Eli Lilly and Company (NYSE: LLY) today announced the successful completion of its acquisition of Akouos, Inc. (NASDAQ: AKUS)…. Continue Reading
Rocket Pharmaceuticals Completes Acquisition of Renovacor
CRANBURY, N.J.–(BUSINESS WIRE)– Rocket Pharmaceuticals, Inc. (NASDAQ: RCKT), a leading late-stage biotechnology company advancing an integrated and sustainable pipeline of genetic therapies… Continue Reading
M&A: Carenet Health Acquires Stericycle Communication Solutions
What You Should Know: Carenet Health, a leading provider of 24/7 and on-demand patient engagement solutions, today announced it has… Continue Reading
Amulet Capital Partners Acquires United Vein & Vascular Centers
TAMPA, Fla. & GREENWICH, Conn.–(BUSINESS WIRE)– Amulet Capital Partners, LP (“Amulet”), a middle-market private equity investment firm focused exclusively on… Continue Reading
German Health Data Company Temedica Scores €25M
German health data startup Temedica raised another €25 million in Series B funding led by existing investor MIG Capital and an undisclosed… Continue Reading
Nectin Therapeutics Raises $25M for Immuno-Oncology Therapies
What You Should Know: Nectin Therapeutics Ltd., (Nectin) a biotechnology company developing novel targeted immunotherapies to address resistance to approved… Continue Reading